FC Stock News
Thursday, May 17, 2007
DUSA Receives Orphan Drug Status
DUSA Pharmaceuticals Inc. (DUSA) announced that it received orphan drug status for its esophageal cancer drug treatment sending the stock price soaring $1.99 to $4.76.
posted by FC Market News at
3:24 PM
0 Comments:
Post a Comment
<< Home
About Me
Name:
FC Market News
View my complete profile
Previous Posts
Earnings Rise For J. C. Penney
Acxiom To Go Private
Doral Financial To Be Sold
Winn-Dixie Swings To Profit
Federal Suit Filed Against Massey Energy
Newfield Exploration To Buy Natural Gas Assets
DSP Group To Buy Unit From NXP
Dr. Reddy's Infringed On Eisai's Patent
Mylan Buys Generic Drug Unit
Viasys To Be Bought By Cardinal Health
0 Comments:
Post a Comment
<< Home